Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and doctor appointments.

Dr. Mohammad Muhsin Chisti

Dr. Mohammad Muhsin Chisti

Medical Oncologist

Dr. Mohammad Muhsin Chisti is a medical oncologist at Beaumont Hospital in Troy, Michigan, who treats a wide range of cancer patients.

Get in touch
Jump to a Topic:

About Mohammad Muhsin Chisti

  • Team Leader icon

    Team Leader

  • 10+ Years of Experience icon

    10+ Years of Experience

  • Pleural and Lung Cancer icon

    Pleural and Lung Cancer

  • Immunotherapy icon


  • Research Excellence icon

    Excellence in Research

In addition to his role at Beaumont, Chisti is the medical director of research at Karmanos Cancer Institute, focusing on novel, targeted therapies that are providing new hope for once-incurable diseases.

“My mission is to provide evidence-based, compassionate care to achieve the best possible outcome, with an emphasis on quality of life,” Chisti said. “I look forward to caring for patients and their families.”

Treating Multiple Cancers

Chisti sees patients with lung cancer, pleural mesothelioma, breast cancer, prostate cancer, multiple myeloma and lymphoma.

As an assistant professor of oncology at Karmanos, he also has affiliations with St. Joseph Mercy Oakland and McLaren Oakland hospitals.

Chisti speaks multiple languages, including Urdu, Kashmiri and Hindi.

He was one of 10 doctors from the staff at Karmanos Cancer Institute who were named to Hour Detroit Magazine’s Top Doctor List 2017.

Chisti is a member of the American Society of Hematology, the American Society of Clinical Oncology and the American College of Physicians.

Breaking New Ground with Immunotherapy

Chisti has co-authored numerous studies involving targeted immunotherapy. One of those in 2018 included combined B-cell and T-cell disorders that lead to debilitating conditions.

In 2019, he co-authored another study in BMJ, formerly British Medical Journal, that illustrated the therapeutic efficacy of the cancer drug lenalidomide in patients with chromosomal disorders.

“Things have changed tremendously [in cancer treatment],” he said. “It’s amazing how much things have changed. We have genetically engineered cells today that are very focused, very targeted that can bind to cancer cells and kill them.”

Before joining Beaumont in 2010, Chisti finished residencies in Internal Medicine at Roswell Park Cancer Institute, the University of Buffalo and State University of New York. He first came to Beaumont as a fellow.

He earned his degree from Government Medical College Srinagar in India. He served as a junior resident at nearby Modern Hospital and then at Sheri-Kashmir Institute of Medical Science.

Disclaimer: Dr. Mohammad Muhsin Chisti has no professional affiliation with

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer. Mesothelioma Packet

Get a Free Treatment Guide Sent Overnight

Get Yours Now

Find Ways to Pay for Treatment Costs

Get Started

Find an Active Mesothelioma Clinical Trial

Find Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Matt Mauney, Content Writer at
Edited by

4 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. Sanders, D. (2019, April 20). MDS with 5q deletion and rare cKIT positive mastocytosis: a diagnostic and therapeutic challenge.
    Retrieved from:
  2. Medscape. (2018, December 16). Combined B-Cell and T-Cell Disorders.
    Retrieved from:
  3. Beaumont. (n.d.). About Mohammad Muhsin Chisti.
    Retrieved from:
  4. Mohammad Muhsin Chisti. (n.d.). About Dr. Chisti. Retrieved from:

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified July 31, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now